Project 3: Single cell measures of intratumor diversity for optimal breast cancer therapy Project Summary / Abstract Despite improved treatment, metastatic breast cancer is still inevitably fatal and is a major cause of cancer- related deaths. Triple negative and inflammatory breast cancer are breast tumor subtypes that lack targeted therapy, which, in combination with the high propensity to distant metastatic spread, leads to poor outcome; 70-80% of patients diagnosed with TNBC or IBC die within 5 years of diagnosis. Thus, new treatment strategies are urgently needed. We have previously analyzed the clinical and functional relevance of intratumor heterogeneity in breast cancer. We analyzed breast tumor samples before and after pre-operative chemotherapy and at different stages of disease progression for intratumor cellular heterogeneity for genetic and phenotypic features. We found that lower pretreatment genetic heterogeneity predicts better response and that distant metastases have the highest diversity index. We have also developed a xenograft model of intratumor clonal heterogeneity in breast cancer and utilized this model to assess the functional relevance of clonal interactions in metastatic progression. We found that polyclonal tumors are more likely to metastasize and identified underlying clonal cooperative mechanisms driving this process. Lastly, we have developed mathematical models based on these experimental data that can infer the evolution of tumors during treatment and disease progression both in clinical samples and in xenografts. Based on our preliminary data, we hypothesize that (1) intratumor heterogeneity is a driver of disease progression, (2) single cell measures of intratumor heterogeneity and their topologic distribution can be used to build mathematical models of tumor evolution and treatment response, (3) the use of these models will aid the design of individualized treatment strategies that more effectively eliminate breast tumors. We propose three specific aims to test these hypotheses:
Aim 1. Single cell analyses of breast tumor samples.
Aim 2. Characterization of therapeutic responses in xenograft models of breast cancer.
Aim 3. Predict optimal therapeutic strategies to prevent metastatic outgrowth and treatment resistance and validate these strategies in xenograft models. Our goal is to translate our findings into future clinical trials.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center--Cooperative Agreements (U54)
Project #
1U54CA193461-01
Application #
8866714
Study Section
Special Emphasis Panel (ZCA1-TCRB-5 (J1))
Project Start
2015-05-19
Project End
2020-04-30
Budget Start
2015-05-19
Budget End
2016-04-30
Support Year
1
Fiscal Year
2015
Total Cost
$392,562
Indirect Cost
$87,287
Name
Dana-Farber Cancer Institute
Department
Type
DUNS #
076580745
City
Boston
State
MA
Country
United States
Zip Code
02215
Ozawa, Tatsuya; Arora, Sonali; Szulzewsky, Frank et al. (2018) A De Novo Mouse Model of C11orf95-RELA Fusion-Driven Ependymoma Identifies Driver Functions in Addition to NF-?B. Cell Rep 23:3787-3797
Cimino, Patrick J; Kim, Youngmi; Wu, Hua-Jun et al. (2018) Increased HOXA5 expression provides a selective advantage for gain of whole chromosome 7 in IDH wild-type glioblastoma. Genes Dev 32:512-523
Stein, Shayna; Zhao, Rui; Haeno, Hiroshi et al. (2018) Mathematical modeling identifies optimum lapatinib dosing schedules for the treatment of glioblastoma patients. PLoS Comput Biol 14:e1005924
Hinohara, Kunihiko; Wu, Hua-Jun; Vigneau, Sébastien et al. (2018) KDM5 Histone Demethylase Activity Links Cellular Transcriptomic Heterogeneity to Therapeutic Resistance. Cancer Cell 34:939-953.e9
Maley, Carlo C; Aktipis, Athena; Graham, Trevor A et al. (2017) Classifying the evolutionary and ecological features of neoplasms. Nat Rev Cancer 17:605-619
Dasgupta, Arko; Lim, Andrea R; Ghajar, Cyrus M (2017) Circulating and disseminated tumor cells: harbingers or initiators of metastasis? Mol Oncol 11:40-61
Gil Del Alcazar, Carlos R; Huh, Sung Jin; Ekram, Muhammad B et al. (2017) Immune Escape in Breast Cancer During In Situ to Invasive Carcinoma Transition. Cancer Discov 7:1098-1115
Kievit, Forrest M; Wang, Kui; Ozawa, Tatsuya et al. (2017) Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma. Nanomedicine 13:2131-2139
Pattwell, Siobhan S; Holland, Eric C (2017) Putting Glioblastoma in Its Place: IRF3 Inhibits Invasion. Trends Mol Med 23:773-776
Peinado, Héctor; Zhang, Haiying; Matei, Irina R et al. (2017) Pre-metastatic niches: organ-specific homes for metastases. Nat Rev Cancer 17:302-317

Showing the most recent 10 out of 36 publications